Tolterodine Tartrate Proniosomal Gel Transdermal Delivery for Overactive Bladder
about
Proniosomes derived niosomes: recent advancements in drug delivery and targeting.Transdermal delivery of tolterodine tartrate for overactive bladder treatment: In vitro and in vivo evaluation.Inhibition of salivary secretion by tolterodine transdermal patch.Development and evaluation of exemestane-loaded lyotropic liquid crystalline gel formulations.Development of controlled release silicone adhesive-based mupirocin patch demonstrates antibacterial activity on live rat skin against Staphylococcus aureus.
P2860
Tolterodine Tartrate Proniosomal Gel Transdermal Delivery for Overactive Bladder
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 31 August 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Tolterodine Tartrate Proniosomal Gel Transdermal Delivery for Overactive Bladder
@en
Tolterodine Tartrate Proniosomal Gel Transdermal Delivery for Overactive Bladder.
@nl
type
label
Tolterodine Tartrate Proniosomal Gel Transdermal Delivery for Overactive Bladder
@en
Tolterodine Tartrate Proniosomal Gel Transdermal Delivery for Overactive Bladder.
@nl
prefLabel
Tolterodine Tartrate Proniosomal Gel Transdermal Delivery for Overactive Bladder
@en
Tolterodine Tartrate Proniosomal Gel Transdermal Delivery for Overactive Bladder.
@nl
P2093
P2860
P1433
P1476
Tolterodine Tartrate Proniosomal Gel Transdermal Delivery for Overactive Bladder
@en
P2093
Jestin Chellian
Srikumar Chakravarthi
P2860
P356
10.3390/PHARMACEUTICS8030027
P577
2016-08-31T00:00:00Z